Displaying 56 - 60 of 180
Sat 11 June 2016
Latest UK data shows that pancreatic cancer patients are missing out on clinical trials as part of their treatment – with less than 5% taking part in pancreatic cancer trials.Read More about 'Hundreds of patients missing out on UK trials'
Fri 03 June 2016
A major pancreatic cancer clinical trial testing the use of a combination of chemotherapy drugs following surgery has shown to improve survival outcomes.Read More about 'Combination therapy after surgery shows improved survival outcomes'
Fri 20 May 2016
We've launched the first-ever interactive UK-wide map and database detailing current clinical trials specifically dedicated to the disease.Read More about 'We launch our new clinical Trial Finder'
Wed 18 May 2016
NICE has annouced that it has brought forward a reappraisal of chemotherapy drug Abraxane for patients with secondary (advanced) pancreatic cancer in England.Read More about 'NICE announces Abraxane reappraisal'
Mon 16 May 2016
We are one of fifteen signatories to an open letter to the Prime Minister - calling on the government to change the methods used to appraise drugs by NICE.Read More about 'Joint open letter to the Prime Minister on Cancer Drugs Fund'